Mesonephric-like adenocarcinoma of the uterine corpus with focal sarcomatous differentiation: A case report.

Fujita Medical Journal Pub Date : 2025-02-01 Epub Date: 2024-10-31 DOI:10.20407/fmj.2024-017
Serika Kanao, Makoto Urano, Kazuhisa Fujita, Fumi Utsumi, Kazuhiro Sugihara, Kiyosumi Shibata
{"title":"Mesonephric-like adenocarcinoma of the uterine corpus with focal sarcomatous differentiation: A case report.","authors":"Serika Kanao, Makoto Urano, Kazuhisa Fujita, Fumi Utsumi, Kazuhiro Sugihara, Kiyosumi Shibata","doi":"10.20407/fmj.2024-017","DOIUrl":null,"url":null,"abstract":"<p><p>Mesonephric-like adenocarcinoma of the uterine corpus was first reported in 2016, and added as a new item to the 5th edition of the WHO classification in 2020. It accounts for approximately 1% of patients with uterine corpus cancer, being rare. The histology of this carcinoma varies, making pathological diagnosis difficult. A diagnosis is made at an advanced stage in comparison with other histological types of uterine corpus cancer, and the prognosis is reportedly poor with high-level malignancy. In addition, there are few case reports of mesonephric-like adenocarcinoma of the uterine corpus with sarcoma. In this study, we report a patient in whom preoperative chemotherapy was performed under a diagnosis of cervical carcinoma, but the resected specimen led to a diagnosis of sarcomatous component-mixed mesonephric-like adenocarcinoma of the uterine corpus after surgery.</p>","PeriodicalId":33657,"journal":{"name":"Fujita Medical Journal","volume":"11 1","pages":"54-58"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11782939/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fujita Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20407/fmj.2024-017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Mesonephric-like adenocarcinoma of the uterine corpus was first reported in 2016, and added as a new item to the 5th edition of the WHO classification in 2020. It accounts for approximately 1% of patients with uterine corpus cancer, being rare. The histology of this carcinoma varies, making pathological diagnosis difficult. A diagnosis is made at an advanced stage in comparison with other histological types of uterine corpus cancer, and the prognosis is reportedly poor with high-level malignancy. In addition, there are few case reports of mesonephric-like adenocarcinoma of the uterine corpus with sarcoma. In this study, we report a patient in whom preoperative chemotherapy was performed under a diagnosis of cervical carcinoma, but the resected specimen led to a diagnosis of sarcomatous component-mixed mesonephric-like adenocarcinoma of the uterine corpus after surgery.

伴有局灶性肉瘤分化的子宫体中肾样腺癌1例。
子宫体中肾样腺癌于2016年首次报道,并于2020年作为新项目加入世界卫生组织第5版分类。它约占子宫体癌患者的1%,是罕见的。这种癌的组织学不同,使病理诊断困难。与其他组织学类型的子宫体癌相比,诊断是在晚期进行的,据报道预后差,恶性程度高。此外,很少有关于子宫体中肾样腺癌合并肉瘤的病例报道。在本研究中,我们报告了一位患者,在诊断为宫颈癌的情况下进行了术前化疗,但手术后切除的标本被诊断为子宫体的肉瘤成分混合介肾样腺癌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信